Highlights
- Phoslock sold 275 tonnes in the September quarter, up from 189 tonnes in June and 251 tonnes a year earlier.
- Phoslock paused production at its Changxing factory after storage filled, following a January restart at the Chinese plant.
- The company is working on a two-year extension to its US distribution agreement, which expires in December 2026.
- Sales growth helped Phoslock move close to Operating Cash Flow break-even in September while a Shareholder class action remained unresolved.
Phoslock Environmental Technologies Limited (ASX:PET), which makes a clay-based product used to lock up phosphorus in polluted lakes and reservoirs, came close to breaking even on operating cash flow in the September quarter as sales recovered. But it has paused production at its Chinese factory because its storage is full, and a shareholder class action that its auditor links to going-concern uncertainty remains unresolved.
What Phoslock does
Sydney-based Phoslock sells Phoslock, a lanthanum-modified bentonite clay that binds phosphate in water and is used to limit harmful algal and cyanobacterial blooms. It manufactures at a plant in Changxing, China, and sells through licensees and distributors, including HydroScience in Brazil and The Orion Companies in the United States. The company was suspended from the ASX for an extended period and was reinstated to Quotation on 14 August 2025.
Sales recovery and a factory pause
According to its quarterly activities report and Appendix 4C dated 22 October 2026, Phoslock sold 275 tonnes in the September quarter, up from 189 tonnes in the June quarter and 251 tonnes a year earlier. Brazil accounted for 61% of Volume and Australia 24%. Sales receipts were AUD 1.13 million and net operating outflow was just AUD 21,000, compared with AUD 952,000 in the same quarter of 2025. The company warned that quarterly cash flows are highly variable.
The Changxing factory, which restarted in January 2026 after a long closure, produced 457 tonnes in the quarter. Production was paused at the end of August once inventory filled the available storage and after several large European projects were deferred to the first quarter of 2027. Inventory stood at 1,848 tonnes on 30 September. The company expects production to resume in the coming months.
New orders and products
On 28 October 2026 Phoslock said it had received purchase orders from The Orion Companies for about 100 tonnes for immediate delivery, taking year-to-date sales to that distributor to 158 tonnes. It also signed a Trademark licence under which Orion can sell blended Phoslock products in the US, paying a 10% Royalty on gross profit; the company does not expect the royalty to be material initially.
The company has also begun batch production of higher-lanthanum formulations. A 700 kg bulk trial of Phoslock 10 has been applied to a pond in Jintan, China, and a Patent application has been filed for 15% and 20% lanthanum versions. These are trials, not commercial sales.
Balance sheet and legal risk
Cash was AUD 3.44 million at 30 September 2026. Auditor SW Audit drew attention to a material uncertainty over Going Concern arising from the Federal Court class action brought by the Banton Group in November 2024. Mediation on 11 June 2026 ended without resolution, no provision has been recognised, and the Quarterly Report says formal court proceedings may not begin until 2027.
Other risks include customer concentration in Brazil, project deferrals in Europe, US tariffs on Chinese-made goods, and the time needed for new products to win regulatory acceptance.
What to watch
The December quarter 4C is due in January 2027.
Share Trading on 16 November
At this price level a one-tick move equals that percentage, and the volume suggests a single small trade.






Please wait processing your request...